What Are Healthy Levels for Thyroid Antibodies

Does your gut need a reset?

Yes, I'm Ready

Do you want to start feeling better?

Yes, Where Do I Start?

Do you want to start feeling better?

Yes, Where Do I Start?

Understanding Thyroid Antibodies: Why Is My Thyroglobulin Antibody High?

Thyroid Autoimmunity and the Importance and Limitations of Elevated Thyroid Antibodies 

Key Points

  • Thyroglobulin antibodies do not appear to correlate with thyroid health, except in select cases.
  • Thyroid peroxidase antibodies (TPO) show greater correlation with thyroid disease and can help monitor disease progression.
  • You should use caution when interpreting the usefulness of thyroid peroxidase antibodies.
  • There are many holistic ways to address elevated thyroid antibody levels and improve thyroid health.

If a recent lab test showed that you have elevated thyroglobulin antibodies, your next question might be “why is my thyroglobulin antibody high?” and, “How can I bring it down to a normal level?” However, when it comes to thyroid antibodies, striving for perfection may be overrated. Elevated levels of thyroid antibodies do not necessarily correlate with your thyroid health or symptoms. 

Thyroglobulin antibodies are notoriously difficult for health care providers to interpret and for patients to understand. Often the level of antibody that is produced does not correlate with clinical hypothyroidism or symptom control.

In this article, we will break down the importance of thyroid antibodies including thyroglobulin and thyroid peroxidase antibodies (TPO), when elevated levels actually matter, and what you can do about it.

I Found Out My Thyroglobulin Antibody Is High. Now What?

Thyroglobulin antibody high: woman with sore throat

Despite thyroglobulin (TG) antibody levels showing a correlation with thyroid health, research supports that they are not a strong predictor of thyroid disease. There are much more reliable tests for diagnosing Hashimoto’s thyroiditis, such as TPO-antibodies, TSH levels, and thyroxine levels. 

Hashimoto’s thyroiditis is a common autoimmune condition that causes the immune system to attack the thyroid gland. In some cases, this leads to hypothyroidism, however this is much less common than many people assume (only about 9-19% of Hashimoto’s patients ever develop hypothyroidism). 

Hashimoto’s is diagnosed by several thyroid function tests, such as [1]:

  • Elevated thyroid stimulating hormone (TSH) levels.
  • Low thyroid hormone levels, reported as free or total T3 and T4
  • Elevated thyroid peroxidase (TPO) antibodies
  • Elevated thyroglobulin (TG) antibodies 
  • Elevated TSH antibodies 

While TPO-antibodies are more indicative of Hashimoto’s thyroiditis, elevated anti-TG antibodies are often reported on lab results, creating concern for patients. 

A 2019 study found that anti-TG antibodies are elevated in 60-80% of patients with Hashimoto’s thyroiditis and in 40-60% of those with Grave’s disease. However, the presence of thyroglobulin antibodies showed only a low-to-moderate sensitivity in diagnosing autoimmune thyroiditis. Additionally, they were not useful in identifying when a patient has transitioned from subclinical to overt hypothyroidism (when hypothyroidism is visible on lab results) [2].

Thyroglobulin antibodies can even be incidental findings in patients with normal thyroid function [2]. This means that patients with no other laboratory signs or physical symptoms of thyroid disease can have elevated thyroglobulin antibodies.

It is no wonder that these elusive antibodies cause so much confusion to health care providers and patients. 

What Are Thyroid Antibodies?

Antibodies are not inherently bad and are actually a very important part of our immune system. When the body detects foreign pathogens, such as bacterial or viral infections, it produces proteins called antibodies. These proteins help recruit other immune cells and fight off intruders. 

However, in some people, the immune system goes awry and starts to produce antibodies against normal body tissue. In the case of thyroid autoimmune disorders, like Hashimoto’s hypothyroidism and Grave’s disease, the immune system mistakenly produces antibodies that attack the thyroid cells.

When they go unchecked, these antibodies can lead to inflammation in the thyroid — known as “thyroiditis.” This destruction to the gland may eventually cause the person to enter a hypothyroid or hyperthyroid state. 

Not everyone who has antithyroid antibodies is hypothyroid, but some people with elevated TPO, TSH, or TG antibodies will eventually become hypothyroid. Furthermore, some patients with thyroid disease may never show elevated levels of any thyroid antibodies [1]. 

Certain Conditions Can Make Your Thyroglobulin Antibody High

Even though antithyroglobulin antibodies are not the best predictor of thyroid disorders, they should not necessarily be ignored. Unlike TPO antibodies, thyroglobulin antibodies are not able to stimulate an immune response in the thyroid, but they may be useful in diagnosing certain thyroid conditions [2, 3].

Anti-TG antibody levels may show importance in the following:

  • Patients diagnosed with thyroid carcinoma who have elevated TG antibodies may be at a higher risk of the cancer spreading to lymph nodes or surrounding organs. Elevated levels may also indicate a high risk of thyroid cancer recurrence after treatment [4].
  • Breast cancer patients may also have high thyroglobulin antibody test results [4].
  • Elevated TG-antibodies may have a higher prevalence in those with autoimmune connective tissue disease. This suggests that screening for thyroid disease in these populations may be beneficial [5]. 

One study found that after successfully treating thyroid disease, thyroglobulin levels dropped back down into normal reference ranges [6]. It is important to point out that this study tested the actual levels of thyroglobulin protein, not the TG-antibody levels. 

However, this finding is consistent with another study that found elevated anti-TG antibodies to correlate with the severity of hypothyroid symptoms, including fragile hair, swelling of the face and eyes, and vocal hoarseness [3].

Thyroglobulin autoantibodies may not be the best indicator of thyroid disease, but likely will continue to be useful in the screening and monitoring of select conditions. 

Thyroglobulin antibody high: person getting a pill from a spoonful of pills

Thyroglobulin and Iodine Levels

Thyroglobulin is a protein secreted by the thyroid gland that aids in the production and storage of thyroid hormones. TG fluctuates with iodine levels, and high thyroglobulin levels may be an indicator of iodine deficiency or excess [7, 8].

Iodine is a nutrient that is essential for the proper functioning of our thyroid gland. Iodine deficiency is an independent risk factor for underactive thyroid and can even lead to the development of a goiter (enlarged thyroid gland) and thyroid nodules [7].

Excess iodine blood levels can create toxicity symptoms, such as stomach pain, nausea and vomiting, and neurological dysfunction. Therefore, screening thyroglobulin levels may be useful in detecting abnormal iodine levels, as iodine is not routinely run on blood tests.

Other Thyroid Antibodies Like TPO May Be More Useful

Thyroid peroxidase antibody (TPO) levels are a much stronger indicator of an increased risk for thyroid disease. TPO antibodies are 90% sensitive in detecting thyroiditis, and are effective in monitoring the progression and severity of thyroid conditions [2].

Unlike thyroglobulin antibodies, TPO antibodies can stimulate the immune system and cause inflammation in thyroid tissue, leading to the development of thyroid disease [2]. However, monitoring anti-TPO antibodies come with their own limitations.

The “normal” reference range for TPO antibodies is less than 35 IU/mL. But a 2016 study published in the Journal of Hormone and Metabolic Research [9] found:

  • Those who had TPO antibodies below 500 IU/mL had a low risk of future progression to hypothyroidism. 
  • Those who were above 500 IU/mL still only had a moderate risk. 

The Tehran Thyroid Study, which followed the course of thyroid disease in a large cohort of people over nine years, showed similar results: those with elevated TPO antibodies only had a 9-19% chance of becoming hypothyroid after 6 years of follow up [10, 11].

If we consider this, elevated thyroid antibodies are not as consequential as many thyroid experts would suggest. 

I’ve commonly seen people with Hashimoto’s disease or elevated thyroid antibodies become hyper-focused on reducing their antibody test results to the “normal” reference range, and becoming unnecessarily stressed. The research suggests this isn’t necessary. 

Instead, it implies that only a minority of patients with elevated TPO antibodies will progress to full hypothyroidism. What this means for you is that you don’t have to continuously pursue lower and lower levels of antibodies with strict diets or supplements, especially if your thyroid symptoms are under control.

If you’re a patient, or a doctor working with patients, it’s important to understand that reducing TPO antibodies to under 500 IU/mL—or getting your thyroid symptoms under control through other means—is a clinical win.

Very High Thyroid Antibodies

All that said, if your TPO antibodies are very high, reducing your antibody count is definitely a worthwhile goal. The higher the TPO antibodies, the more likely you are to develop hypothyroidism.

The farther you reduce your TPO antibodies, even if you can’t get them down to 500 IU/mL, the less damage to your thyroid gland. Just don’t feel discouraged by failing to get them down to the “normal” reference range.

4 Ways to Reduce Thyroid Antibodies

There are several ways you can reduce your thyroid antibodies and improve your thyroid function, using diet and lifestyle.

1. Improve Your Gut Health

Preliminary evidence suggests that gut health is closely linked to thyroid health and that improving gut health can decrease thyroid antibodies and balance your thyroid hormones. Here are several ways you can work on improving your gut health.

  • Anti-Inflammatory Diet: A low-quality diet is typically the single biggest source of inflammation that can impair your thyroid and immune function. But encouragingly, early evidence shows that changing your diet can lower thyroid antibodies.

    A low-carbohydrate diet was shown in one study to reduce thyroid antibodies by 44% in people with Hashimoto’s thyroiditis, but not celiac disease [12], while a gluten-free diet was shown to reduce thyroid antibodies in a group of women with Hashimoto’s thyroiditis [13]. Other studies have shown that eliminating dairy or gluten may help improve thyroid function [14, 15]. A Paleo diet template is low carb, dairy-free, and gluten-free, and may be a good place to start.

    You may have heard of the Autoimmune Paleo diet, which has been shown in one small study to reduce thyroid symptoms and inflammatory markers [16]. Many clinicians have seen their autoimmune patients respond well to the Autoimmune Paleo diet. However, the diet has yet to be shown to reduce thyroid antibodies. This doesn’t mean it’s not useful, but it may not be necessary to follow such a restricted diet to reduce thyroid antibodies.
  • Gut Infections: Gut infections, such as H. pylori, SIBO (small intestinal bacterial overgrowth), and Blastocystis hominis are associated with elevated thyroid antibodies. Treating these infections may reduce thyroid antibodies [17, 18, 19, 20, 21].
  • Probiotics: Probiotics have been shown in multiple studies to improve the gut infections that are associated with elevated thyroid antibodies, including H. pylori infection and SIBO (see above) [22, 23]. In another study, probiotics didn’t appear to improve thyroid antibodies, however, they did reduce the need for thyroid medication [24]. More research is needed to confirm this effect, but probiotics appear to improve thyroid function.
  • Digestive Support: Research shows that up to 40% of hypothyroid patients also have stomach autoimmunity, resulting in low stomach acid [25, 26]. Basic digestive supports such as digestive enzymes or stomach acid support may help thyroid function [27].

2. Supplements

  • Selenium: Several studies, including a meta-analysis (the highest quality science) show selenium improves thyroid antibodies for hypothyroid patients [28, 29, 30]. However, not all research agrees, and more studies need to be done.
  • Vitamin D: Research suggests that vitamin D deficiency is associated with higher levels of thyroid antibodies [31], and that supplementation may decrease thyroid antibodies [32].
  • CoQ10 & Magnesium: Some evidence suggests CoQ10 and Magnesium supplementation may reduce thyroid antibodies. CoQ10 has been shown to “improve thyroid vascularity,” and magnesium supports iodine uptake [33]. One small study demonstrated supplementation with magnesium, CoQ10, and selenium along with additional supports reduced thyroid antibodies [34], while one additional study showed an association between low serum magnesium and thyroid antibodies [35].
  • For more on supplements to support thyroid function, see How Should I Use Thyroid Supplements?
Woman getting an infrared facial

3. Light Therapy

There are some encouraging data showing that low-level laser therapy can improve thyroid function and decrease TPO antibodies. The therapy also reduced the amount of levothyroxine medication the patients needed, even after nine months of follow-up [36, 37].

4. Optimize Iodine Levels

Iodine is an important nutrient for the thyroid gland, but must be used cautiously. Supplemental dietary iodine has been shown in several population-based studies to increase the incidence of autoimmune thyroid diseases [38, 39]. On the other hand, too little iodine can also cause thyroid symptoms. Optimizing your iodine levels may reduce thyroid antibodies.

For more on how to optimize your iodine, including how to test, see How Should I Use Thyroid Supplements?

Final Thoughts on Thyroid Antibodies

In summary, high thyroglobulin antibody levels likely hold little clinical relevance to the presence and severity of thyroid disease. TPO antibodies are a greater indicator of thyroid health and can be used to monitor the progression of thyroid dysfunction. 

However, even TPO antibodies come with their own limitations. Unless your TPO antibodies are very high, it’s not necessary to be hyper-focused on reducing your thyroid antibodies to the lab reference range. Reducing elevated TPO thyroid antibodies to below 500 IU/mL, and improving your thyroid function with diet and lifestyle changes significantly reduces your risk of developing hypothyroidism.

If you want help with reducing thyroglobulin antibody high levels or reducing thyroid symptoms, schedule an appointment at our center for functional health.

The Ruscio Institute has developed a range of high quality formulations to help our patients and audience. If you’re interested in learning more about these products, please click here. Note that there are many other options available, and we encourage you to research which products may be right for you.

➕ References
  1. Mincer DL, Jialal I. Hashimoto Thyroiditis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 29083758.
  2. Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, et al. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367. DOI: 10.1016/j.beem.2019.101367. PMID: 31812326.
  3. Barić A, Brčić L, Gračan S, Škrabić V, Brekalo M, Šimunac M, et al. Thyroglobulin Antibodies are Associated with Symptom Burden in Patients with Hashimoto’s Thyroiditis: A Cross-Sectional Study. Immunol Invest. 2019 Feb;48(2):198–209. DOI: 10.1080/08820139.2018.1529040. PMID: 30332318.
  4. Pan X-F, Ma Y-J, Tang Y, Yu M-M, Wang H, Fan Y-R. Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysis. Breast Cancer. 2020 Sep;27(5):828–36. DOI: 10.1007/s12282-020-01078-z. PMID: 32279180.
  5. Wang Q, Shangguan J, Zhang Y, Pan Y, Yuan Y, Que W. The prevalence of thyroid autoantibodies in autoimmune connective tissue diseases: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2020 Sep 7;16(9):923–30. DOI: 10.1080/1744666X.2020.1811089. PMID: 32811198.
  6. Bílek R, Dvořáková M, Grimmichová T, Jiskra J. Iodine, thyroglobulin and thyroid gland. Physiol Res. 2020 Sep 30;69(Suppl 2):S225–36. DOI: 10.33549/physiolres.934514. PMID: 33094621.
  7. Du Y, Gao YH, Feng ZY, Meng FG, Fan LJ, Sun DJ. Serum Thyroglobulin-A Sensitive Biomarker of Iodine Nutrition Status and Affected by Thyroid Abnormalities and Disease in Adult Populations. Biomed Environ Sci. 2017 Jul;30(7):508–16. DOI: 10.3967/bes2017.067. PMID: 28756810.
  8. Wan S, Jin B, Ren B, Qu M, Wu H, Liu L, et al. The Relationship between High Iodine Consumption and Levels of Autoimmune Thyroiditis-Related Biomarkers in a Chinese Population: a Meta-Analysis. Biol Trace Elem Res. 2020 Aug;196(2):410–8. DOI: 10.1007/s12011-019-01951-9. PMID: 31713113.
  9. Ehlers M, Jordan AL, Feldkamp J, Fritzen R, Quadbeck B, Haase M, et al. Anti-Thyroperoxidase Antibody Levels >500 IU/ml Indicate a Moderately Increased Risk for Developing Hypothyroidism in Autoimmune Thyroiditis. Horm Metab Res. 2016 Sep 8;48(10):623–9. DOI: 10.1055/s-0042-112815. PMID: 27607246.
  10. Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study. PLoS ONE. 2017 Jan 4;12(1):e0169283. DOI: 10.1371/journal.pone.0169283. PMID: 28052092. PMCID: PMC5215694.
  11. Amouzegar A, Ghaemmaghami Z, Beigy M, Gharibzadeh S, Mehran L, Tohidi M, et al. Natural course of euthyroidism and clues for early diagnosis of thyroid dysfunction: tehran thyroid study. Thyroid. 2017 May;27(5):616–25. DOI: 10.1089/thy.2016.0409. PMID: 28071990.
  12. Esposito T, Lobaccaro JM, Esposito MG, Monda V, Messina A, Paolisso G, et al. Effects of low-carbohydrate diet therapy in overweight subjects with autoimmune thyroiditis: possible synergism with ChREBP. Drug Des Devel Ther. 2016 Sep 14;10:2939–46. DOI: 10.2147/DDDT.S106440. PMID: 27695291. PMCID: PMC5028075.
  13. Krysiak R, Szkróbka W, Okopień B. The Effect of Gluten-Free Diet on Thyroid Autoimmunity in Drug-Naïve Women with Hashimoto’s Thyroiditis: A Pilot Study. Exp Clin Endocrinol Diabetes. 2019 Jul;127(7):417–22. DOI: 10.1055/a-0653-7108. PMID: 30060266.
  14. Virili C, Bassotti G, Santaguida MG, Iuorio R, Del Duca SC, Mercuri V, et al. Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 2012 Mar;97(3):E419-22. DOI: 10.1210/jc.2011-1851. PMID: 22238404.
  15. Asik M, Gunes F, Binnetoglu E, Eroglu M, Bozkurt N, Sen H, et al. Decrease in TSH levels after lactose restriction in Hashimoto’s thyroiditis patients with lactose intolerance. Endocrine. 2014 Jun;46(2):279–84. DOI: 10.1007/s12020-013-0065-1. PMID: 24078411.
  16. Abbott RD, Sadowski A, Alt AG. Efficacy of the Autoimmune Protocol Diet as Part of a Multi-disciplinary, Supported Lifestyle Intervention for Hashimoto’s Thyroiditis. Cureus. 2019 Apr 27;11(4):e4556. DOI: 10.7759/cureus.4556. PMID: 31275780. PMCID: PMC6592837.
  17. Brechmann T, Sperlbaum A, Schmiegel W. Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study. World J Gastroenterol. 2017 Feb 7;23(5):842–52. DOI: 10.3748/wjg.v23.i5.842. PMID: 28223728. PMCID: PMC5296200.
  18. Konrad P, Chojnacki J, Kaczka A, Pawłowicz M, Rudnicki C, Chojnacki C. [Thyroid dysfunction in patients with small intestinal bacterial overgrowth]. Pol Merkur Lekarski. 2018 Jan 23;44(259):15–8. PMID: 29374417.
  19. Choi YM, Kim TY, Kim EY, Jang EK, Jeon MJ, Kim WG, et al. Association between thyroid autoimmunity and Helicobacter pylori infection. Korean J Intern Med. 2017 Mar;32(2):309–13. DOI: 10.3904/kjim.2014.369. PMID: 28092700. PMCID: PMC5339455.
  20. Bertalot G, Montresor G, Tampieri M, Spasiano A, Pedroni M, Milanesi B, et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf). 2004 Nov;61(5):650–2. DOI: 10.1111/j.1365-2265.2004.02137.x. PMID: 15521972.
  21. El-Zawawy HT, Farag HF, Tolba MM, Abdalsamea HA. Improving Hashimoto’s thyroiditis by eradicating Blastocystis hominis: Relation to IL-17. Ther Adv Endocrinol Metab. 2020 Feb 21;11:2042018820907013. DOI: 10.1177/2042018820907013. PMID: 32128107. PMCID: PMC7036484.
  22. Eslami M, Yousefi B, Kokhaei P, Jazayeri Moghadas A, Sadighi Moghadam B, Arabkari V, et al. Are probiotics useful for therapy of Helicobacter pylori diseases? Comp Immunol Microbiol Infect Dis. 2019 Jun;64:99–108. DOI: 10.1016/j.cimid.2019.02.010. PMID: 31174707.
  23. Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol. 2017 Apr;51(4):300–11. DOI: 10.1097/MCG.0000000000000814. PMID: 28267052.
  24. Talebi S, Karimifar M, Heidari Z, Mohammadi H, Askari G. The effects of synbiotic supplementation on thyroid function and inflammation in hypothyroid patients: A randomized, double‑blind, placebo‑controlled trial. Complement Ther Med. 2020 Jan;48:102234. DOI: 10.1016/j.ctim.2019.102234. PMID: 31987229.
  25. Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009 Nov 7;15(41):5121–8. DOI: 10.3748/wjg.15.5121. PMID: 19891010. PMCID: PMC2773890.
  26. Sterzl I, Hrdá P, Matucha P, Čeřovská J, Zamrazil V. Anti-Helicobacter Pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res. 2008 Feb 13;57 Suppl 1:S135–41. DOI: 10.33549/physiolres.931498. PMID: 18271683.
  27. Cellini M, Santaguida MG, Virili C, Capriello S, Brusca N, Gargano L, et al. Hashimoto’s thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne). 2017 Apr 26;8:92. DOI: 10.3389/fendo.2017.00092. PMID: 28491051. PMCID: PMC5405068.
  28. Wichman J, Winther KH, Bonnema SJ, Hegedüs L. Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis. Thyroid. 2016 Dec;26(12):1681–92. DOI: 10.1089/thy.2016.0256. PMID: 27702392.
  29. Gärtner R, Gasnier BCH. Selenium in the treatment of autoimmune thyroiditis. Biofactors. 2003;19(3–4):165–70. DOI: 10.1002/biof.5520190309. PMID: 14757967.
  30. Gärtner R, Gasnier BCH, Dietrich JW, Krebs B, Angstwurm MWA. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002 Apr;87(4):1687–91. DOI: 10.1210/jcem.87.4.8421. PMID: 11932302.
  31. Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M, et al. The association between severity of vitamin D deficiency and Hashimoto’s thyroiditis. Endocr Pract. 2013 Jun;19(3):479–84. DOI: 10.4158/EP12376.OR. PMID: 23337162.
  32. Wang S, Wu Y, Zuo Z, Zhao Y, Wang K. The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis. Endocrine. 2018 Mar;59(3):499–505. DOI: 10.1007/s12020-018-1532-5. PMID: 29388046.
  33. Moncayo R, Moncayo H. A post-publication analysis of the idealized upper reference value of 2.5 mIU/L for TSH: Time to support the thyroid axis with magnesium and iron especially in the setting of reproduction medicine. BBA Clin. 2017 Jun;7:115–9. DOI: 10.1016/j.bbacli.2017.03.003. PMID: 28409122. PMCID: PMC5385584.
  34. Moncayo R, Moncayo H. Proof of concept of the WOMED model of benign thyroid disease: Restitution of thyroid morphology after correction of physical and psychological stressors and magnesium supplementation. BBA Clin. 2015 Jun;3:113–22. DOI: 10.1016/j.bbacli.2014.12.005. PMID: 26672672. PMCID: PMC4661508.
  35. Wang K, Wei H, Zhang W, Li Z, Ding L, Yu T, et al. Severely low serum magnesium is associated with increased risks of positive anti-thyroglobulin antibody and hypothyroidism: A cross-sectional study. Sci Rep. 2018 Jul 2;8(1):9904. DOI: 10.1038/s41598-018-28362-5. PMID: 29967483. PMCID: PMC6028657.
  36. Höfling DB, Chavantes MC, Juliano AG, Cerri GG, Knobel M, Yoshimura EM, et al. Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial. Lasers Med Sci. 2013 May;28(3):743–53. DOI: 10.1007/s10103-012-1129-9. PMID: 22718472.
  37. Höfling DB, Chavantes MC, Juliano AG, Cerri GG, Romão R, Yoshimura EM, et al. Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers Surg Med. 2010 Aug;42(6):589–96. DOI: 10.1002/lsm.20941. PMID: 20662037.
  38. Foley TP. The relationship between autoimmune thyroid disease and iodine intake: a review. Endokrynol Pol. 1992;43 Suppl 1:53–69. PMID: 1345585.
  39. Katagiri R, Yuan X, Kobayashi S, Sasaki S. Effect of excess iodine intake on thyroid diseases in different populations: A systematic review and meta-analyses including observational studies. PLoS ONE. 2017 Mar 10;12(3):e0173722. DOI: 10.1371/journal.pone.0173722. PMID: 28282437. PMCID: PMC5345857.

Need help or would like to learn more?
View Dr. Ruscio’s, DC additional resources

Get Help

Discussion

I care about answering your questions and sharing my knowledge with you. Leave a comment or connect with me on social media asking any health question you may have and I just might incorporate it into our next listener questions podcast episode just for you!